BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mirici-Cappa F, Caraceni P, Domenicali M, Gelonesi E, Benazzi B, Zaccherini G, Trevisani F, Puggioli C, Bernardi M. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol 2011; 17(30): 3479-3486 [PMID: 21941414 DOI: 10.3748/wjg.v17.i30.3479]
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3479.htm
Number Citing Articles
1
Saqib Walayat, Daniel Martin, Jaymon Patel, Umair Ahmed, Muhammad N. Asghar, Aparna U. Pai, Sonu Dhillon. Role of albumin in cirrhosis: from a hospitalist’s perspectiveJournal of Community Hospital Internal Medicine Perspectives 2017; 7(1): 8 doi: 10.1080/20009666.2017.1302704
2
Mauro Bernardi, Caterina Maggioli, Giacomo Zaccherini. Human albumin in the management of complications of liver cirrhosisCritical Care 2012; 16(2) doi: 10.1186/cc11218
3
Hitesh Kumar Dewangan. Sustainable Agriculture Reviews 43Sustainable Agriculture Reviews 2020; 43: 239 doi: 10.1007/978-3-030-41838-0_8
4
Alexander H. Flannery, Komal Pandya, Melanie E. Laine, Philip J. Almeter, Jeremy D. Flynn. Managing the Rising Costs and High Drug Expenditures in Critical Care Pharmacy PracticePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2017; 37(1): 54 doi: 10.1002/phar.1862
5
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Predicting mortality for hepatorenal syndrome with liver‐specific scoresGastroHep 2020; 2(6): 336 doi: 10.1002/ygh2.429
6
Hela Elloumi, Mériam Sabbah, Norsaf Bibani, Dorra Trad, Nour Elleuch, Dalila Gargouri, Asma Ouakaa, Jamel Kharrat. Effect of low dose albumin administration in spontaneous bacterial peritonitis on renal function and survivalArab Journal of Gastroenterology 2019; 20(4): 205 doi: 10.1016/j.ajg.2019.11.002
7
David Mario Rodrigues, Maya Djerboua, Jennifer A Flemming. Intravenous Albumin in Patients With Cirrhosis: Evaluation of Practice Patterns and Secular Trends of Usage in Ontario 2000 to 2017Journal of the Canadian Association of Gastroenterology 2021; 4(4): 179 doi: 10.1093/jcag/gwaa027
8
M. Bernardi, C. Maggioli, G. Zaccherini. Annual Update in Intensive Care and Emergency Medicine 20122012; : 421 doi: 10.1007/978-3-642-25716-2_39
9
Paolo Caraceni, Marco Pavesi, Maurizio Baldassarre, Mauro Bernardi, Vicente Arroyo. The use of human albumin in patients with cirrhosis: a European surveyExpert Review of Gastroenterology & Hepatology 2018; 12(6): 625 doi: 10.1080/17474124.2018.1460203
10
Shoroq M. Altawalbeh, Rawan Abu- Su’Ud, Qais Alefan, Suleiman Mohammad Momany, Sandra L. Kane-Gill. Evaluating intensive care unit medication charges in a teaching hospital in JordanExpert Review of Pharmacoeconomics & Outcomes Research 2019; 19(5): 561 doi: 10.1080/14737167.2019.1571413
11
Yoshiteru Yano, Nobuo Sakata, Kiyohide Fushimi. Establishing a hospital transfusion management system promotes appropriate clinical use of human albumin in Japan: a nationwide retrospective studyBMC Health Services Research 2019; 19(1) doi: 10.1186/s12913-019-4836-0
12
Paolo Caraceni, Paolo Angeli, Daniele Prati, Mauro Bernardi, Carlo Alessandria, Oliviero Riggio, Francesco Salerno, Giancarlo Maria Liumbruno, Francesco Bennardello, Pierluigi Piccoli, Claudio Velati, Pierluigi Berti, Giuseppina Facco, Francesco Fiorin. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosisDigestive and Liver Disease 2016; 48(1): 4 doi: 10.1016/j.dld.2015.11.008
13
Paolo Caraceni, Marco Domenicali, Alessandra Tovoli, Lucia Napoli, Carmen Serena Ricci, Manuel Tufoni, Mauro Bernardi. Clinical indications for the albumin use: Still a controversial issueEuropean Journal of Internal Medicine 2013; 24(8): 721 doi: 10.1016/j.ejim.2013.05.015
14
Mauro Bernardi, Carmen S. Ricci, Giacomo Zaccherini. Role of Human Albumin in the Management of Complications of Liver CirrhosisJournal of Clinical and Experimental Hepatology 2014; 4(4): 302 doi: 10.1016/j.jceh.2014.08.007
15
Yuliya Afinogenova, Elliot B. Tapper. The efficacy and safety profile of albumin administration for patients with cirrhosis at high risk of hepatorenal syndrome is dose dependentGastroenterology Report 2015; 3(3): 216 doi: 10.1093/gastro/gov032
16
Guruprasad P Aithal, Naaventhan Palaniyappan, Louise China, Suvi Härmälä, Lucia Macken, Jennifer M Ryan, Emilie A Wilkes, Kevin Moore, Joanna A Leithead, Peter C Hayes, Alastair J O'Brien, Sumita Verma. Guidelines on the management of ascites in cirrhosisGut 2021; 70(1): 9 doi: 10.1136/gutjnl-2020-321790
17
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortalityGastroenterología y Hepatología 2021;  doi: 10.1016/j.gastrohep.2021.02.007
18
Montserrat Costa, Antonio Páez. Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease managementTransfusion and Apheresis Science 2021; 60(3): 103164 doi: 10.1016/j.transci.2021.103164